" /> Docetaxel/Trastuzumab Regimen - CISMeF





Preferred Label : Docetaxel/Trastuzumab Regimen;

NCIt synonyms : Docetaxel/Trastuzumab; Taxotere/Herceptin; Docetaxel-Trastuzumab Regimen; Docetaxel-Trastuzumab;

NCIt related terms : Docetaxel and Trastuzumab (TH); Docetaxel and Trastuzumab-qyyp (TH); T-H (Docetaxel) (trastuzumab-pkrb); Docetaxel and Trastuzumab-herw (TH); T-H (Docetaxel) (trastuzumab-herw); Docetaxel and Trastuzumab-dttb (TH); T-H (Docetaxel) (trastuzumab-zerc); Docetaxel and Trastuzumab-anns (TH); Docetaxel and Trastuzumab-pkrb (TH); T-H (Docetaxel) (trastuzumab-anns); T-H (Docetaxel) (trastuzumab-dttb); T-H (Docetaxel); T-H (Docetaxel) (trastuzumab-qyyp); T-H (Docetaxel) (trastuzumab-dkst); Docetaxel and Trastuzumab-zerc (TH); Docetaxel and Trastuzumab-dkst (TH);

NCIt definition : A regimen consisting of docetaxel and trastuzumab that may be used in the treatment of breast, esophageal and esophagogastric junction, and gastric cancers and salivary gland tumors. Docetaxel every 21 days plus trastuzumab regimen may be used for the treatment of breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524997;

Codes from synonyms : 6130; 129028; 136264; 128931; 128834; 136269; 136266; 129222; 136265; 136268; 129125; 136267; 129416; 136271; 136270; 129319;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
09/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.